Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02443402 · ClinicalTrials.gov registry record · Phase 4
Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 68
- Enrollment target
NCT02443402: Completed Phase 4 study, sponsored by Emory University.
NCT02443402 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 68 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02443402, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to compare sitagliptin and placebo for the prevention of high blood glucose during surgery.
Primary Outcome
Number of participants who developed stress hyperglycemia (BG \>180 mg/dl) during coronary artery bypass grafting (CABG) or after CABG requiring continuous IV insulin infusion (CII) while in the ICU.
Interventions
- DRUG Placebo
- DRUG Sitagliptin
- DRUG Insulin glargine
- DRUG Regular Human Insulin
- DRUG Supplemental insulin (Insulin lispro)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
What the finished NCT02443402 record still lists
NCT02443402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT02443402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02443402 about?
NCT02443402 is a clinical study titled "Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery". The purpose of this study is to compare sitagliptin and placebo for the prevention of high blood glucose during surgery.
What is the current status of trial NCT02443402?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 68 participants. The study started on 2016-01. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02443402?
The interventions under investigation include: Placebo (DRUG), Sitagliptin (DRUG), Insulin glargine (DRUG), Regular Human Insulin (DRUG), Supplemental insulin (Insulin lispro) (DRUG).
Who is sponsoring clinical trial NCT02443402?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02443402's enrollment target sits among peer trials
68 1076th of 2000 higher than 918 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia